Skip to product information
1 of 1

GeneBio Systems

AGR2 Polyclonal Antibody

AGR2 Polyclonal Antibody

SKU:E-AB-13798

Regular price $718.20 CAD
Regular price Sale price $718.20 CAD
Sale Sold out
Shipping calculated at checkout.

Size: 200μL

Storage: Store at -20℃ Valid for 12 months. Avoid freeze / thaw cycles.

Shipping: The product is shipped with ice pack,upon receipt,store it immediately at the temperature recommended.

Exp date: 12 months

Category ID_II: Primary Antibodies

Category ID_III: Polyclonal Antibodies

Abbreviation: AGR2

Target Synonym: AG 2;AG 2 protein;AG-2;AG2;AG2 protein;AGR 2;AGR2;AGR2;Anterior gradient 2 homolog (Xenopus laevis);anterior gradient 2 homolog;Anterior gradient 2;protein disulphide isomerase family member;Anterior gradient 2;Xenopus;homolog of;Anterior gradient homolog 2;Anterior gradient protein 2 homolog;Epididymis secretory protein Li 116;GOB 4;GOB4;HAG 2;hAG-2;hAG2;HAG2/R;HEL S 116;HPC 8;hPC8;PDIA17;Protein disulfide isomerase family A member 17;secreted cement gland homolog;Secreted cement gland protein XAG 2 homolog;Secreted cement gland protein XAG-2 homolog;Secreted cement gland protein XAG2 homolog;XAG 2;XAG2

Research Areas: Cancer;Developmental Biology;Stem Cells

Conjugation: Unconjugated

Host: Rabbit

Species reactivity: Human;Mouse

Application: WB

Isotype: IgG

Clonality: Polyclonal

Clone NO.:

UNIProt ID: O95994

Accession:

Background: Anterior gradient protein 2 homolog (AGR2) is a human protein originally discovered in Xenopus laevis, encoded for by the gene of the same name.In Xenopus AGR2 is an important role in cement gland differentiation, however in human cancer cell lines high levels of AGR2 correlate with reduction of the p53 response and AGR2 levels are elevated in the preneoplastic tissue Barrett's oesophagus.

Concentration: 0.7 mg/mL

Immunogen: Recombinant protein of human AGR2

Buffer: PBS with 0.05% sodium azide and 50% glycerol, PH7.4

Purification method: Affinity purification

Dilution: WB 1:1000-1:5000

Calculated MW: 20kDa

ObservedMW:

View full details